Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-AraG Biodistribution in NSCLC
NCT04052412Phase 1Unknown
- Sponsor
- University of Tennessee
- Start
- Jul 2019
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of fluorine f 18 ara-g in non-small cell lung cancer (NSCLC) (2 arms), sponsored by University of Tennessee. Primary endpoints: Biodistribution of 18F-AraG and Kinetics of 18F-AraG. Status: unknown.
02
Drugs
fluorine f 18 ara-g
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT04052412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052412.